These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28769571)

  • 21. Prognostic significance of microRNA-135 in patients with digestive system cancers: a systematic review and meta-analysis.
    Chao C; Sang C; Wang M; Wang Z; Li Y; Luo G; Zhang X
    Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31803920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic effect of programmed death-ligand 1 (PD-L1) in ovarian cancer: a systematic review, meta-analysis and bioinformatics study.
    Wang L
    J Ovarian Res; 2019 Apr; 12(1):37. PubMed ID: 31039792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of PD-L1 expression in tumor infiltrating immune cells in cancers: A meta-analysis.
    Zhao T; Li C; Wu Y; Li B; Zhang B
    PLoS One; 2017; 12(4):e0176822. PubMed ID: 28453554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of Caspase-3 expression in cancers of digestive tract: a meta-analysis and systematic review.
    Chen H; Yang X; Feng Z; Tang R; Ren F; Wei K; Chen G
    Int J Clin Exp Med; 2015; 8(7):10225-34. PubMed ID: 26379814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic and clinicopathological value of PD-L1 expression in primary breast cancer: a meta-analysis.
    Huang W; Ran R; Shao B; Li H
    Breast Cancer Res Treat; 2019 Nov; 178(1):17-33. PubMed ID: 31359214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Prognostic Value of Circulating Soluble Programmed Death Ligand-1 in Cancers: A Meta-Analysis.
    Huang P; Hu W; Zhu Y; Wu Y; Lin H
    Front Oncol; 2020; 10():626932. PubMed ID: 33718120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Clinicopathologic and Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1) Expression in Patients With Prostate Cancer: A Systematic Review and Meta-Analysis.
    Li Y; Huang Q; Zhou Y; He M; Chen J; Gao Y; Wang X
    Front Pharmacol; 2018; 9():1494. PubMed ID: 30733677
    [No Abstract]   [Full Text] [Related]  

  • 28. Soluble PD-L1 Expression in Circulation as a Predictive Marker for Recurrence and Prognosis in Gastric Cancer: Direct Comparison of the Clinical Burden Between Tissue and Serum PD-L1 Expression.
    Shigemori T; Toiyama Y; Okugawa Y; Yamamoto A; Yin C; Narumi A; Ichikawa T; Ide S; Shimura T; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Ohi M; Araki T; Kusunoki M
    Ann Surg Oncol; 2019 Mar; 26(3):876-883. PubMed ID: 30565045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
    Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
    JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The expression status and prognostic significance of programmed cell death 1 ligand 1 in gastrointestinal tract cancer: a systematic review and meta-analysis.
    Huang B; Chen L; Bao C; Sun C; Li J; Wang L; Zhang X
    Onco Targets Ther; 2015; 8():2617-25. PubMed ID: 26451118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinicopathological and prognostic value of programmed death-ligand 1 in colorectal cancer: a meta-analysis.
    Ni X; Sun X; Wang D; Chen Y; Zhang Y; Li W; Wang L; Suo J
    Clin Transl Oncol; 2019 May; 21(5):674-686. PubMed ID: 30392153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PD-L1 Expression in Glioblastoma, the Clinical and Prognostic Significance: A Systematic Literature Review and Meta-Analysis.
    Hao C; Chen G; Zhao H; Li Y; Chen J; Zhang H; Li S; Zhao Y; Chen F; Li W; Jiang WG
    Front Oncol; 2020; 10():1015. PubMed ID: 32670884
    [No Abstract]   [Full Text] [Related]  

  • 33. Prognostic Value of Soluble Programmed Cell Death Ligand-1 (sPD-L1) in Various Cancers: A Meta-analysis.
    Li X; Zheng Y; Yue F
    Target Oncol; 2021 Jan; 16(1):13-26. PubMed ID: 33222017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic and Clinicopathological Value of Programmed Cell Death Ligand1 Expression in Patients With Small Cell Lung Cancer: A Meta-Analysis.
    Cai H; Zhang H; Jiang Y
    Front Oncol; 2020; 10():1079. PubMed ID: 32670887
    [No Abstract]   [Full Text] [Related]  

  • 35. Prognostic and Clinicopathological Role of PD-L1 in Endometrial Cancer: A Meta-Analysis.
    Lu L; Li Y; Luo R; Xu J; Feng J; Wang M
    Front Oncol; 2020; 10():632. PubMed ID: 32426281
    [No Abstract]   [Full Text] [Related]  

  • 36. Prognostic Role of PD-L1 Expression in Invasive Breast Cancer: A Systematic Review and Meta-Analysis.
    Cirqueira MB; Mendonça CR; Noll M; Soares LR; de Paula Carneiro Cysneiros MA; Paulinelli RR; Moreira MAR; Freitas-Junior R
    Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Values of LAPTM4B-35 in Human Cancer: A Meta-analysis.
    Zhou L; Dai C; Tian T; Wang M; Lin S; Deng Y; Xu P; Hao Q; Wu Y; Yang T; Zhu W; Dai Z
    J Cancer; 2018; 9(23):4355-4362. PubMed ID: 30519340
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical value of Xenopus kinesin-like protein 2 as a prognostic marker in patients with digestive system cancers: a systematic review and meta-analysis.
    Wang G; Wang Q; Li Z; Liu C; He X
    Onco Targets Ther; 2018; 11():1229-1243. PubMed ID: 29551902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic values of HE4 expression in patients with cancer: a meta-analysis.
    Dai C; Zheng Y; Li Y; Tian T; Wang M; Xu P; Deng Y; Hao Q; Wu Y; Zhai Z; Dai Z; Lyu J
    Cancer Manag Res; 2018; 10():4491-4500. PubMed ID: 30349381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of programmed cell death-ligand 1 expression in patients with non-small-cell lung cancer: evidence from an updated meta-analysis.
    Zhong A; Xing Y; Pan X; Shi M; Xu H
    Onco Targets Ther; 2015; 8():3595-601. PubMed ID: 26664143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.